Positive feedbacks of coagulation: their role in threshold regulation.
暂无分享,去创建一个
[1] Macfarlane Rg,et al. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .
[2] R. Macfarlane. An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.
[3] S. Levine,et al. Enzyme Amplifier Kinetics , 1966, Science.
[4] R. Canfield,et al. Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.
[5] B. Osterud,et al. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. , 1979, Blood.
[6] J. Dunn,et al. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.
[7] J. Jesty,et al. The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombin. , 1981, Blood.
[8] W. Owen,et al. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. , 1982, The Journal of clinical investigation.
[9] R. Bertina,et al. Activation of Human Coagulation Factor VIII by Activated Factor X, the Common Product of the Intrinsic and the Extrinsic Pathway of Blood Coagulation , 1982, Thrombosis and Haemostasis.
[10] M. Griffith,et al. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors. , 1983, The Journal of clinical investigation.
[11] P. Lollar,et al. Reaction of antithrombin III with thrombin bound to the vascular endothelium. Analysis in a recirculating perfused rabbit heart preparation. , 1984, The Journal of biological chemistry.
[12] K. Mann,et al. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency. , 1984, The Journal of clinical investigation.
[13] P. Lollar,et al. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. , 1984, Blood.
[14] J Jesty,et al. The kinetics of inhibition of alpha-thrombin in human plasma. , 1986, The Journal of biological chemistry.
[15] M. Richardson,et al. On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro. , 1986, Blood.
[16] J. Jesty. Analysis of the generation and inhibition of activated coagulation factor X in pure systems and in human plasma. , 1986, The Journal of biological chemistry.
[17] R. Ralph,et al. A speculation on the nature of chromosomal DNA. , 1988, Journal of theoretical biology.
[18] Susan G. Brown,et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.
[19] M A Khanin,et al. A mathematical model of the kinetics of blood coagulation. , 1989, Journal of theoretical biology.
[20] K. Nakamura,et al. Measuring tissue factor (factor III) activity in plasma. , 1989, Clinical chemistry.
[21] H. Hemker,et al. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. , 1989, Blood.
[22] M. Bednarek,et al. DETECTION OF FACTOR X ACTIVATION IN HUMANS , 1989, Thrombosis and Haemostasis.
[23] H. ten Cate,et al. Factor IX is activated in vivo by the tissue factor mechanism. , 1990, Blood.
[24] Jean Pieters,et al. Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma. , 1990, Blood.
[25] W. Kisiel,et al. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. , 1991, Biochemistry.
[26] Interaction of feedback control and product inhibition in the activation of factor X by factors IXa and VIII. , 1991, Haemostasis.
[27] G. Broze,et al. Factor XI activation in a revised model of blood coagulation , 1991, Science.
[28] W. Kisiel,et al. Tissue factor-dependent autoactivation of human blood coagulation factor VII. , 1992, The Journal of biological chemistry.
[29] J. Jesty,et al. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate. , 1992, Archives of biochemistry and biophysics.
[30] P. Neuenschwander,et al. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. , 1992, The Journal of biological chemistry.
[31] P. Comp,et al. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation , 1993 .
[32] E. Beltrami,et al. Mathematical analysis of a proteolytic positive-feedback loop: dependence of lag time and enzyme yields on the initial conditions and kinetic parameters. , 1993, Biochemistry.
[33] F. Ataullakhanov,et al. Calcium threshold in human plasma clotting kinetics. , 1994, Thrombosis research.
[34] K. Mann,et al. A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, Journal of Biological Chemistry.
[35] T. Koyama,et al. Determination of plasma tissue factor antigen and its clinical significance , 1994, British journal of haematology.
[36] U. Hedin,et al. Thrombogenicity of the Injured Vessel Wall – Role of Antithrombin and Heparin , 1994, Thrombosis and Haemostasis.
[37] D. Hoppensteadt,et al. Tissue factor antigen levels in various biological fluids , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[38] Y. Nemerson,et al. Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface. , 1995, Biophysical journal.
[39] J Jesty,et al. Mathematical analysis of activation thresholds in enzyme-catalyzed positive feedbacks: application to the feedbacks of blood coagulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Altieri,et al. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. , 1996, The Biochemical journal.
[41] I. Tsuji,et al. Increased plasma tissue factor levels in acute myocardial infarction. , 1997, American heart journal.
[42] Kenneth G. Mann,et al. Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II* , 1997, The Journal of Biological Chemistry.
[43] A. Gori,et al. Elevated Tissue Factor and Tissue Factor Pathway Inhibitor Circulating Levels in Ischaemic Heart Disease Patients , 1998, Thrombosis and Haemostasis.
[44] J. Badimón,et al. Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Badimón,et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. , 2000, Blood.
[46] P. Walsh,et al. Thrombin-mediated Feedback Activation of Factor XI on the Activated Platelet Surface Is Preferred over Contact Activation by Factor XIIa or Factor XIa* , 2000, The Journal of Biological Chemistry.
[47] H. K. Kim,et al. Changes of Plasma Tissue Factor and Tissue Factor Pathway Inhibitor Antigen Levels and Induction of Tissue Factor Expression on the Monocytes in Coronary Artery Disease , 2000, Cardiology.
[48] N. Mackman,et al. Measurement of Tissue Factor Activity in Whole Blood , 2000, Thrombosis and Haemostasis.
[49] J Jesty,et al. The role of membrane patch size and flow in regulating a proteolytic feedback threshold on a membrane: possible application in blood coagulation. , 2001, Mathematical biosciences.
[50] A. Fogelson,et al. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. , 2001, Biophysical journal.
[51] J. Fallon,et al. In situ localization of tissue factor in human thrombi. , 2002, Blood.
[52] K. C. Jones,et al. A Model for the Stoichiometric Regulation of Blood Coagulation* , 2002, The Journal of Biological Chemistry.
[53] J. Chou,et al. Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.
[54] Sharene D. Bungay,et al. A mathematical model of lipid-mediated thrombin generation. , 2003, Mathematical medicine and biology : a journal of the IMA.
[55] Y. Nemerson,et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein , 2003, Nature Medicine.
[56] Nigel Mackman,et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. , 2004, Blood.
[57] G. Lip,et al. Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus: Relationships to Cardiovascular Disease and Risk Factor Intervention , 2004, Circulation.
[58] J. Silveira,et al. Unique in Vivo Modifications of Coagulation Factor V Produce a Physically and Functionally Distinct Platelet-derived Cofactor , 2004, Journal of Biological Chemistry.
[59] E. Beltrami,et al. Demonstration of a Threshold Response in a Proteolytic Feedback System: Control of the Autoactivation of Factor XII , 2006, Pathophysiology of Haemostasis and Thrombosis.
[60] K. Mann,et al. Tissue factor activity in whole blood. , 2005, Blood.
[61] P. Walsh. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor-XI activation by thrombin. , 2007, Biochemistry.